Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 2010, for Parametric Sound Corporation (trading as "PAMT"). The company is a newly independent entity formed via a spin-off from LRAD Corporation on September 27, 2010, focusing on HyperSonic Sound (HSS) technology. As of the reporting date, the company is in a pre-revenue stage, developing a new product line (HSS-III) and has ceased sales of the legacy H450 product previously sold by LRAD.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2010 | Three Months Ended Dec 31, 2009 |
|---|---|---|
| Total Revenues | $0 | $95,802 |
| Net Loss | $(325,940) | $(58,178) |
| Loss Per Share (Basic & Diluted) | $(0.02) | $(0.00) |
| Cash and Cash Equivalents (End of Period) | $215,844 | $0 |
| Net Cash Used in Operating Activities | $(213,600) | $19,435 |
| Total Current Assets | $236,035 | $460,370 |
| Total Current Liabilities | $658,724 | $611,705 |
| Working Capital Deficit | $(422,689) | $(151,335) |
| Subordinated Notes Payable (Principal) | $700,000 | N/A |
Material Changes vs. Prior Period
- Revenue Cessation: Revenues dropped to zero from $95,802 in the prior year quarter. The company explicitly stated it has no plans to sell the legacy H450 product line and is awaiting the launch of a new product line.
- Increased Operating Expenses: Total operating expenses surged to $255,741 from $81,630. This increase is driven by the transition to a standalone public company, including higher Selling, General, and Administrative (SG&A) costs ($129,344 vs. $43,870) and Research and Development (R&D) costs ($112,155 vs. $16,959).
- Debt Financing: The company issued $700,000 in 8% Subordinated Promissory Notes in September 2010, resulting in significant non-cash interest expense ($56,161 amortization of debt discount) and accrued interest ($14,422) not present in the prior period.
- Liquidity Position: Cash reserves decreased by $223,541 during the quarter due to operating losses and capital expenditures, despite the recent debt financing.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management has raised substantial doubt about the company's ability to continue as a going concern. The company has a working capital deficit of $422,689 and relies on obtaining additional financing to sustain operations for the next 12 months.
- Capital Requirements: The company estimates a need for a minimum of $300,000 in additional capital to maintain planned operations and refinance or repay the $700,000 in notes due September 28, 2011.
- Product Development: Future revenues are entirely dependent on the successful development and market acceptance of the new HSS-III product line. No assurance is given regarding the timing or success of this launch.
- Internal Control Weaknesses: The company disclosed material weaknesses in internal controls, specifically the lack of an independent audit committee and insufficient segregation of duties (the CFO initiates, records, and reconciles transactions).
- Related Party Obligations: The company is obligated to pay a 5% royalty on future revenues to Syzygy Licensing LLC (owned by executive officers) and has accrued officer compensation of $52,500.
Investor Verification Checklist
- Financing Status: Verify if the company has secured the estimated $300,000+ in additional capital required to bridge the gap until product launch or debt maturity.
- Product Timeline: Confirm the current status of the HSS-III product development and the expected date for commercial availability.
- Debt Maturity: Monitor the status of the $700,000 subordinated notes due September 28, 2011, and any refinancing efforts.
- Internal Controls: Check for updates on the formation of an independent audit committee and remediation of segregation of duties issues.
- Related Party Transactions: Review the terms of the royalty agreement with Syzygy Licensing LLC and the accrual of officer compensation.